🚀This Multiple Myeloma Awareness Month, we're dedicated to pushing the boundaries of innovation to improve patient outcomes. 🌟 Learn more about our commitment to cutting-edge solutions here at @PredictaBiosci . 🔬 #MyelomaAwarenessMonth
This week, our team gathered to focus on this year's goals. We are inspired and very excited about the work ahead and the impactful data we will generate to support both patients and clinicians.
Last night was above par as we celebrated the holiday spirit with our incredible team & had fun putting around! Celebrating the achievements of 2024 and excited for what the future holds. Wishing everyone a joyful holiday season and a prosperous year ahead!
🌟Welcome to Predicta Biosciences, @JulianMHess🌟
Julian joins Predicta Biosciences as Principal Computational Biologist, bringing expertise from @getz_lab@broadinstitute. We're thrilled to have him on board to advance our mission of impactful patient solutions!
Happy Thanksgiving from @PredictaBiosci!
Our recent lunch was a wonderful opportunity to celebrate!
During this season of gratitude, we want to thank our investors, clinicians, partners,& especially patients for your support.
Wishing everyone a joyful & fulfilling holiday!
Aparna Raval, PhD, SVP of Translational Research, will attend the upcoming #ASH24. If you are interested in learning more about GenoPredicta and Immunopredicta platforms for multiple myeloma and other hematological malignancies, please email us [email protected]
A huge thank you to the BrightEdge - @AmericanCancer for hosting such impactful events & to Farnaz Bakhshi for moderating a fantastic session. It was a true pleasure to meet ACS President Karen Knudsen MBA, PhD.
Thank you to @wilsonsonsini, for your support and sponsorship!
Thrilled to have been part of the recent Myeloma Committee, where Valentina Nardi delivered an insightful presentation on our work! A big thank you to @szusmani for the kind invitation. We are inspired by the innovative trials being conducted in the myeloma space!
Thrilled to have been part of the recent Myeloma Committee, where Valentina Nardi delivered an insightful presentation on our work! A big thank you to @szusmani for the kind invitation. We are inspired by the innovative trials being conducted in the myeloma space!
Next week, we’re thrilled to be participating in events hosted by Brightedge - @AmericanCancer
🌟Monday: BrightEdge Entrepreneurs Pitch
🌟Tuesday: Join Kate Caves & industry leaders for a Panel Discussion, Fostering Founders & Entrepreneurs Across the Innovation Impasse
🌟 Inspiring Insights from the Cancer Diagnostics Panel @ the Oncology Venture, Innovation & Partnering Summit! 🌟
🔑 Key Takeaway
Harnessing Multi-omics for Precision Medicine
Thanks to Mara Aspinall, Tom Miller, Lisa Alderson,
Anthony Chang, Alan Hirzel, and Darshana Zaveri
We had the pleasure of attending the #ToughTechSummit, where Kate Caves delivered an inspiring talk on innovations to enhance diagnostic capabilities and advance treatments for diseases like multiple myeloma. 💡🔬
A huge thanks to @theEngineAccelerator & @engineventures !
We are committed to advancing the fight against blood cancers. This September, we join the global community in raising awareness, supporting research & advocating for patients battling these challenging conditions.
#BloodCancerAwarenessMonth#MultipleMyeloma#CancerResearch
Join us in welcoming Danielle Sookiasian as our new Principal Scientist!
She recently was a Principal Scientist & Group Leader at BostonGene. Her passion lies in assay development in molecular biology & genomics, & automating solutions for high-throughput applications.
Join us in extending a warm welcome @francoisaguet Head of Computational Biology! François was previously an Associate Director @illumina AI lab and @broadinstitute in GetzLab.org where his research focused on understanding the genetic basis of human diseases.
1K Followers 1K FollowingSmoldering Multiple Myeloma (HR by PETHEMA) in 2012. Fast forward to 2019, downgraded to IR by 20-2-20. PCROWD & IMPACT clincial trial participant.ModernaVax x5
22 Followers 259 FollowingDedicated to collaborating with healthcare professionals, biotech and pharma to bring cutting-edge therapies and diagnostics to patients
782 Followers 2K FollowingMD-PhD, Instructor at @DanaFarber and @BroadInstitute working on Multiple Myeloma and Waldenstrom's genomics/immunology. Founder @PredictaBiosci 🏳️🌈(he/him)
8K Followers 7K FollowingEvolution, statistics, software, slacktivism. Once left a tenure track job, but trying to get one again. @docedge85 and @mwpen pay my bills
381 Followers 161 FollowingComputational Biologist | Head of computational biology @PredictaBiosci | Previously group leader @illumina AI lab and @broadinstitute
22 Followers 259 FollowingDedicated to collaborating with healthcare professionals, biotech and pharma to bring cutting-edge therapies and diagnostics to patients
25K Followers 323 FollowingThe Oncologist Journal focuses on medical and practice issues of busy oncology, hematology and radiation professionals to aid in better cancer patient care.
8K Followers 218 FollowingVincent Rajkumar, Professor of Medicine. My academic account and posting content on behalf of Mayo Clinic Myeloma Group. https://t.co/ctiIw6tva8
6K Followers 486 FollowingMary and Bill Battle Professor of Multiple Myeloma. Immunotherapy , cellular therapy, clinical trials. I unapologetically believe MM can be CURED.
72K Followers 258 FollowingCancer Cell provides a high-profile forum for showcasing advances in cancer research, with a strong emphasis on translational research.
4K Followers 2K FollowingWorking hard to bring novel therapies, drug combinations and diagnostics to blood cancer patient.Tweets are my own #precisionmedicine #mmsm #leusm #lymsm
2K Followers 289 FollowingAssociate Professor, Multiple Myeloma Section Chief and Research Lead, Dept of Lymphoma Myeloma, UT MD Anderson Cancer Center, dog lover
2K Followers 934 FollowingMyeloma, Waldenstroms, Amyloidosis, CAR-T and Cellular Therapy Specialist at UT Southwestern Medical Center (tweets are my own)
75K Followers 1K FollowingNature Reviews Cancer is a monthly review journal for researchers working on cancer. We, the editors, highlight the most exciting topics in cancer research.
4K Followers 496 FollowingDirector of the Myeloma & Amyloidosis Service @columbiacancer - Associate Editor @JCO_ASCO-Tweets are my own
https://t.co/eoOACqg46y
22K Followers 230 FollowingFollow Cancer Discovery for high-impact articles and news covering major advances in basic, translational, and clinical cancer research. Published by @AACR.
4K Followers 378 FollowingAsst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://t.co/mPeWg1QRrW
848 Followers 218 FollowingPhysician scientist @BrighamHeme and @DFCI. Former @BrighamMedRes. Heme malignancy. Clonal hematopoiesis. Multiple myeloma. Live in Boston but root for LA.
782 Followers 2K FollowingMD-PhD, Instructor at @DanaFarber and @BroadInstitute working on Multiple Myeloma and Waldenstrom's genomics/immunology. Founder @PredictaBiosci 🏳️🌈(he/him)
9K Followers 252 FollowingProfessor at @EmoryUniversity, Chair of Dept. Hem & Med Onc at @EmoryMedicine, Chief Medical Officer @WinshipAtEmory. Opinions=my own. #mmsm
16K Followers 5K FollowingDeputy Chair of Lymphoma/Myeloma, Vice Chair MM Research @ MD Anderson; Translational researcher who hates myeloma. Tweets are my own. Retweets ≠ endorsements.
17K Followers 4K FollowingImproving the quality of life of myeloma patients while working toward prevention & cure by focusing on four key areas: research, education, support, & advocacy
9K Followers 2K FollowingA global online platform providing the latest treatment options & medical information on multiple myeloma https://t.co/I985R5jtY7 #mmsm #myeloma
381 Followers 161 FollowingComputational Biologist | Head of computational biology @PredictaBiosci | Previously group leader @illumina AI lab and @broadinstitute
21K Followers 4K FollowingMultiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patient’s lives, and lead to a cure.